Jones, ByronRyan, MandyCook, Nigel S.Gutzwiller, Florian S2024-07-162024-07-162024-05-02Jones, B, Ryan, M, Cook, N S & Gutzwiller, F S 2024, 'Development of a disease-specific health utility score for Chronic Obstructive Pulmonary Disease from a Discrete Choice Experiment patient preference study', International Journal of Technology Assessment in Health Care, vol. 40, no. 1, e30. https://doi.org/10.1017/S02664623240002420266-4623https://hdl.handle.net/2164/23831Open Access via the CUP Agreement Acknowledgements; We wish to acknowledge the support of Katie Mycock, Tom Gardner, Phil Mellor, Pam Hallworth, Kate Sully, Sophi Tatlock, Beyza Klein, Gerard Criner, Pierre-Régis Burgel, Olivier Le Rouzic, Kip Adams, Kirsten Phillips, Mike McKevitt, and Kazuko Toyama for their involvement and contributions to the design, conduct and analysis of this patient preference study, and Kevin Marsh for comments and suggestions for further analyses based on a manuscript draft. Funding statement: The study was funded in full by Novartis Pharma AG. Byron Jones and Nigel Cook are employees of Novartis Pharma AG. At the time of writing, Florian Gutzwiller was an employee of Novartis Pharma AG.8534533engDisease-specific health utility scoreChronic Obstructive Pulmonary DiseaseEQ56 5D-3LPatient preferenceR MedicineSupplementary Informationhttp://doi.org/10.1017/S0266462324000242RJournal article10.1017/S0266462324000242401